Squamous cell cancer of hypopharynx and larynx – Evaluation of metastatic nodal disease based on computed tomography perfusion studies-Reference-Cited by-同舟云学术

Squamous cell cancer of hypopharynx and larynx – Evaluation of metastatic nodal disease based on computed tomography perfusion studies

Published:2012-05 Issue:5 Volume:81 Page:1034-1039
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Trojanowska A.,Trojanowski P.,Bisdas S.,Staśkiewicz G.,Drop A.,Klatka J.,Bobek-Billewicz B.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference22 articles.

1. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck;Don;Laryngoscope,1995

2. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis;Som;AJR,1992

3. Computed tomography of cervical lymph nodes; staging and management of head and neck cancer;Stevens;Arch Otolaryngol,1985

4. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer;Sumi;AJNR Am J Neuroradiol,2003

5. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging;Vandecaveye;Radiology,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between microvascular density and perfusion parameters derived from dynamic contrast-enhanced computed tomography in dogs with tumors of the head;Veterinary Oncology;2024-07-16

2. Dynamic contrast‐enhanced computed tomography in dogs with nasal tumors;Journal of Veterinary Internal Medicine;2023-04-24

3. Arterial spin labeling and diffusion-weighted imaging for identification of retropharyngeal lymph nodes in patients with nasopharyngeal carcinoma;Cancer Imaging;2022-08-17

4. Advanced CT and MR Imaging of the Posttreatment Head and Neck;Neuroimaging Clinics of North America;2022-02

5. Imaging Evaluation of Thymoma and Thymic Carcinoma;Frontiers in Oncology;2022-01-03